Atopic Dermatitis: Reimbursement Challenges

2016-12-06 20:17:00
Tags: Atopic Dermatitis,Crisaborole,pediatric eczema,psoriasis,severe Atopic Dermatitis,Ustekinumab,specialty pharmacy

Panelists Peter L. Salgo, MD; Ed Pezalla, MD, MPH; Jeffrey D. Dunn, PharmD, MBA; Cheryl Allen, BS Pharm, MBA; and Jonathan Silverberg, MD, PhD, MPH, outline translating clinical trial results and some of the reimbursement challenges when treating patients with atopic dermatitis.